L. Lagneaux

AMD3100 disrupts the cross-talk between chronic lymphocytic leukemia cells and a mesenchymal stromal or nurse-like cell-based microenvironment: pre-clinical evidence for its association with chronic lymphocytic leukemia treatments

Basile Stamatopoulos, Nathalie Meuleman, C. De Bruyn et al. · Haematologica · 2011 · 64 citations · Full text

Medicine, Oncology, Pharmacology +17

From skeletal muscle to stem cells: an innovative and minimally-invasive process for multiple species

Justine Ceusters, J.P. Lejeune, Charlotte Sandersen et al. · Scientific Reports · 2017 · 39 citations · Full text

Life Sciences, Biotechnology, Immunology +17

Reduced intensity conditioning haematopoietic stem cell transplantation with mesenchymal stromal cells infusion for the treatment of metachromatic leukodystrophy: a case report

Nathalie Meuleman, G. Vanhaelen, Tatiana Tondreau et al. · Haematologica · 2007 · 35 citations · Full text

Medicine, Hematology, Neurology +15

Gene expression profiling reveals differences in microenvironment interaction between patients with chronic lymphocytic leukemia expressing high versus low ZAP70 mRNA

Basile Stamatopoulos, Benjamin Haibe‐Kains, Carole Equeter et al. · Haematologica · 2009 · 35 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces apoptosis, down-regulates the CXCR4 chemokine receptor and impairs migration of chronic lymphocytic leukemia cells

Basile Stamatopoulos, Nathalie Meuleman, C. De Bruyn et al. · Haematologica · 2010 · 30 citations · Full text

Life Sciences, Oncology, Pharmacology +17